Medical research

Tirzepatide weight-loss study shows promising results

After 12 initial weeks of weight loss with intensive lifestyle intervention alone, participants in the SURMOUNT-3 study who were randomly assigned to tirzepatide for 72 weeks achieved a total mean reduction in baseline body ...

Diabetes

Metabolically healthy obesity: Fact or fiction?

A session at this year's Annual Meeting of the European Association for the Study of Diabetes will explore the latest data on the concept of metabolically healthy obesity (MHO)—more commonly known by the public as "fat ...

page 15 from 40